Bentley Systems Announces Acquisition of Mobility Simulation Leader INRO
15.4.2021 01:04:00 EEST | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the acquisition of INRO Software, a global leader in multimodal transportation planning, traffic simulation, and mobility visualization software. The acquisition expands Bentley’s capabilities in the important growth area of mobility digital twins, just as countries including the U.S. are poised to make a generational investment in infrastructure, and as transportation systems must evolve faster to accommodate both urbanization and carbon reduction goals, and the transition to electric and autonomous vehicles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005928/en/
Image produced with Emme (www.inrosoftware.com/emme) using data from Metro (https://www.oregonmetro.gov/) (Image courtesy of INRO)
INRO, based in Montreal, Quebec, Canada, has for more than 40 years contributed to the advancement of mobility simulation and modeling for metropolitan, regional, and national transport and transit operators and planning agencies. Users of its multimodal simulation offerings include some of the world’s busiest transit systems and metros, such as Transport for London, Transport for New South Wales, the Washington State Department of Transportation, the Swedish Transport Administration Trafikverket, and the public transport system of São Paulo SPTrans.
INRO’s products include Emme, a multimodal transportation planning system for urban, regional, and national transportation forecasting; Dynameq, a vehicle-based traffic simulation platform for city-wide traffic planning; and CityPhi, a mobility visualization solution providing data visualization and visual analytics of large-scale mobility and geospatial datasets.
Combining the capabilities of INRO’s advanced traffic and vehicle simulation with Bentley’s passenger and pedestrian simulation and civil design software, including CUBE, Streetlytics, LEGION, and OpenRoads, places Bentley in a very strong position to deliver comprehensive mobility digital twins of multimodal transportation systems at urban, metropolitan, regional, and national scale.
Advancing Mobility Digital Twins
Urban planners are seeking to understand the ongoing impacts—on transportation system performance, reliability, and accessibility—of the new opportunities and challenges of private and shared mobility, the propensity for cycling or walking, connected autonomous vehicles, and potential congestion charging. With respect to their traditionally circumscribed use of transportation modeling tools in isolation and only on occasion, multiple advantages are now attainable through mobility digital twins, which can be continuously updated with as-operated engineering conditions and with observed traffic data. Mobility digital twins bring these functions together so that infrastructure planning and simulations can be continuously valuable throughout engineering, construction, and operations.
The pandemic experience reinforces the resilience value of sustaining “evergreen” planning and engineering modeling and simulation to maintain fitness for purpose during unanticipated eventualities. With the priority now on “building back better,” it is increasingly recognized that the most economical way to augment infrastructure capacity, while accomplishing the needed energy transitions toward climate sustainability, is to optimize the utilization, configuration, and life extension of existing mobility assets, while adding integrated and appealing public transit options.
This requirement now sets the stage for mobility digital twins that need to be multimodal, need detailed dynamic traffic assignment and agent-based methods for veracity, and need to scale up to systemwide and regionwide—uniquely hallmarks of INRO. As the leader in infrastructure digital twins, Bentley’s iTwin platform can now bring together—with the best-validated aggregate and individual vehicle and pedestrian simulation—3D/4D continuous surveying and reality modeling, civil engineering and project delivery, and asset and network performance. Ultimately, the opportunity for digital cities is to save their constituents time in their day, while at the same time improving congestion and climate resilience, and safety.
“We are very pleased to welcome INRO to Bentley Systems,” said Robert Mankowski, senior vice president, digital cities, Bentley Systems. “Professor Michael Florian and his team led the research of advanced multimodal network modeling methods which helped establish state-of-the-art mobility simulation, and in this next generation his son Dan is leading its software future in our mobility digital twin advancement. With the addition of INRO and its world-class team, Bentley Systems can even better accelerate cities and regions in going digital to ‘build back better’!”
Dr. Michael Florian, founder of INRO, said, “Bentley is a recognized leader in transportation across the infrastructure lifecycle from planning and design to heavy civil construction and road network management. My colleagues and I are very excited to join Bentley and to help realize the vision shared by thousands of cities and urban regions throughout the world to improve their sustainability and quality of life.”
Image 1: Emme
Caption: Image produced with Emme (www.inrosoftware.com/emme) using data from Metro (https://www.oregonmetro.gov/)
Image 2: Dynameq
Caption: Image produced with Dynameq (www.inrosoftware.com/dynameq) using data from SFCTA (https://www.sfcta.org/)
Image 3: CityPhi
Caption: Image produced with CityPhi (www.inrosoftware.com/cityphi) using data from http://www.andresmh.com/nyctaxitrips/
Image 4: INRO Products
Caption: INRO is a global leader in multimodal transportation planning, traffic simulation, and mobility visualization software
Video: Seattle synthetic travel demand model
Caption: Illustration of ~20 million activities completed over the course of a day by 3.6 million people from a synthesized travel demand model of the Seattle metropolitan region. Activities are shown as time-animated vertical extrusions of population movements colored by purpose. The heads-up display summarizes the visible population by current activity. Video prepared by INRO using CityPhi (www.inrosoftware.com/cityphi). More information on source data, provided by PSRC, is available at https://www.psrc.org/activity-based-travel-model-soundcast.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley, the Bentley logo, AssetWise, CUBE, INRO, Emme, Dynameq, CityPhi, iTwin, LEGION, MicroStation, OpenRoads, ProjectWise, and Streetlytics are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005928/en/
Contact information
Press:
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
